We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
-1.83%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$696M
AUM Growth
-$17.3M
Cap. Flow
-$537K
Cap. Flow %
-0.08%
Top 10 Hldgs %
15.81%
Holding
288
New
40
Increased
95
Reduced
57
Closed
17

Top Buys

Rank Stock Value
1
FRSH icon
Freshworks
FRSH
+$10.8M
2
JBL icon
Jabil
JBL
+$4.39M
3
GSK icon
GSK
GSK
+$4.1M
4
NOV icon
NOV
NOV
+$3.97M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$3.76M

Top Sells

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$11.3M
2
VNM icon
VanEck Vietnam ETF
VNM
+$7M
3
CHX
ChampionX
CHX
+$4.45M
4
GPN icon
Global Payments
GPN
+$4.34M
5
UNH icon
UnitedHealth
UNH
+$4.03M

Sector Composition

Rank Sector Weight
1 Technology 31.67%
2 Industrials 12.69%
3 Healthcare 11.3%
4 Energy 7.93%
5 Financials 4.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADBE icon
176
Adobe
ADBE
$89.5B
$243K 0.03%
437
+5
+1% +$2.42K
SO icon
177
Southern Company
SO
$110B
$243K 0.03%
3,127
– –
RSG icon
178
Republic Services
RSG
$66.7B
$243K 0.03%
1,248
– –
CL icon
179
Colgate-Palmolive
CL
$72.6B
$241K 0.03%
2,487
– –
NVS icon
180
Novartis
NVS
$295B
$237K 0.03%
+2,225
New +$223K
VRSK icon
181
Verisk Analytics
VRSK
$26.4B
$227K 0.03%
+841
New +$206K
UVSP icon
182
Univest Financial
UVSP
$1.23B
$226K 0.03%
9,884
– –
CSX icon
183
CSX Corp
CSX
$98.6B
$216K 0.03%
6,458
– –
MDT icon
184
Medtronic
MDT
$107B
$215K 0.03%
2,728
+131
+5% +$10.7K
NEM icon
185
Newmont
NEM
$98.2B
$209K 0.03%
+5,000
New +$204K
AVB icon
186
AvalonBay Communities
AVB
$27.1B
$207K 0.03%
+999
New +$193K
PEG icon
187
Public Service Enterprise Group
PEG
$39.8B
$206K 0.03%
+2,792
New +$198K
BRK.B icon
188
Berkshire Hathaway Class B
BRK.B
$1.07T
$203K 0.03%
500
– –
EGRX
189
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$67.2K 0.01%
12,000
– –
DNN icon
190
Denison Mines
DNN
$2.63B
$23.6K ﹤0.01%
11,854
-1,023
-8% -$2.17K
ACN icon
191
Accenture
ACN
$89.9B
– –
-939
Closed -$325K
ADI icon
192
Analog Devices
ADI
$181B
– –
-1,379
Closed -$273K
BKNG icon
193
Booking.com
BKNG
$138B
– –
-1,575
Closed -$229K
CHX
194
DELISTED
ChampionX
CHX
– –
-124,066
Closed -$4.45M
CTAS icon
195
Cintas
CTAS
$82.4B
– –
-1,424
Closed -$245K
GPN icon
196
Global Payments
GPN
$22.1B
– –
-32,441
Closed -$4.34M
RF icon
197
Regions Financial
RF
$26.3B
– –
-10,280
Closed -$216K
STE icon
198
Steris
STE
$20.9B
– –
-17,413
Closed -$3.91M
ULTA icon
199
Ulta Beauty
ULTA
$20.4B
– –
-6,899
Closed -$3.61M
UNH icon
200
UnitedHealth
UNH
$382B
– –
-8,150
Closed -$4.03M
5 6 7
8
9

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q2 2024 Portfolio in Review

As of Q2 2024, Stanley-Laman Group held 288 positions worth $696M, down 2.4% from $713M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Stanley-Laman Group's Q2 2024 filing shows 40 new, 95 increased, 57 reduced and 17 closed positions. Its largest new stake was Freshworks: 719,687 shares worth $9.13M. The largest sale was HashiCorp, Inc. Class A Common Stock, an estimated $11.3M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Industrials and Healthcare.

  • Stanley-Laman Group's largest Q2 2024 buy was Freshworks: 719,687 shares worth $9.13M.
  • Stanley-Laman Group added most to GSK in Q2 2024, an estimated $4.1M increase.
  • Stanley-Laman Group's biggest Q2 2024 reduction was Eli Lilly, cutting an estimated $3.55M.
  • Stanley-Laman Group fully exited HashiCorp, Inc. Class A Common Stock in Q2 2024, selling an estimated $11.3M.
  • Stanley-Laman Group's ten largest holdings make up 16% of its $696M portfolio in Q2 2024.
  • Stanley-Laman Group opened 40 new positions and closed 17 in Q2 2024.
  • Stanley-Laman Group's portfolio value fell 2.4% quarter-over-quarter to $696M.

Based on Stanley-Laman Group's 13F filing for Q2 2024, filed 18 Jul 2024.